Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2014 | Viamet Pharmaceuticals | $60.0M Series D | Adrian Howd, Woodford Investment Management | Hatteras Venture Partners, Astellas Venture Management, Intersouth Partners, Lilly Ventures, Novartis |
| Jan 4, 2012 | CytoPherx | $34.0M Other Equity | Capital Midwest Fund, Michael Bunker, Leslie Bottorff | Aphelion Capital, Apjohn Ventures, Charter Oak Equity, Dow/Union Carbide Employee Pension Plans, Emergent Medical Partners, Kaiser Permanente Ventures, North Coast Technology Investors |
| Jun 18, 2010 | CytoPherx | $5.0M Series B | Diamond Capital Management | Apjohn Ventures |
| Jan 8, 2010 | Discera | $11.0M Series D | — | Ardesta, Horizon Ventures, Bill White, Scale Venture Partners |